Considering that the initial event which triggers neuronal degradation in Alzheimer’s disease is enhanced Aß generation and aggregation [41], CP function would be an important therapeutic target for the prevention of AD development. The gene discussed is CP; the disease is early-onset autosomal dominant Alzheimer disease.